Result of Surgical Resection for Pulmonary Metastasis from Urothelial Carcinoma.
- Author:
Woo Sik HAN
1
;
Kwhanmien KIM
;
Joon Suk PARK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
Lung neoplasms;
Metastasectomy
- MeSH:
Hospital Mortality;
Humans;
Length of Stay;
Lung Neoplasms;
Metastasectomy;
Neoplasm Metastasis;
Postoperative Complications;
Retrospective Studies
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2012;45(4):242-245
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Treatment of pulmonary metastasis from urothelial cell carcinoma has been mostly palliative chemotherapy and the role of pulmonary metastasectomy has not been investigated much. MATERIALS AND METHODS: This study is a retrospective interim review of pulmonary metastasectomy from urothelial carcinoma at single institution between 1998 and 2010. Overall 16 patients underwent pulmonary metastasectomies. RESULTS: There was no postoperative complication or hospital mortality. Mean hospital stay was 6 days. Overall and disease-free 5-year survival were 65.3% and 37.5%, respectively. CONCLUSION: In selected patients with pulmonary metastasis from urothelial carcinoma, surgical treatment is feasible and could contribute to long-term survival in selected patients.
